SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-029508
Filing Date
2005-02-14
Accepted
2005-02-14 17:15:14
Documents
5
Period of Report
2005-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 29802
2 SUMMARY OF AMENDMENT TO THE INVITROGEN CORPORATION 2005 INCENTIVE PLAN dex991.htm EX-99.1 3857
3 FORM OF NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT dex992.htm EX-99.2 41532
4 FORM OF NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT dex993.htm EX-99.3 27029
5 SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM dex994.htm EX-99.4 6146
  Complete submission text file 0001193125-05-029508.txt   110720
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25317 | Film No.: 05612349
SIC: 2836 Biological Products, (No Diagnostic Substances)